Global justice and the COVID-19 vaccine: Limitations of the public goods framework
| Autor: | Nivedita Saksena |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
COVID-19 Vaccines
Health Care Rationing 030505 public health Global justice Equity (economics) media_common.quotation_subject Public Health Environmental and Occupational Health COVID-19 Context (language use) Redistribution (cultural anthropology) Public good Global Health Democracy 03 medical and health sciences 0302 clinical medicine Social Justice Global public good Global health Humans 030212 general & internal medicine Business 0305 other medical science media_common Law and economics |
| Zdroj: | Global Public Health. 16:1512-1521 |
| ISSN: | 1744-1706 1744-1692 |
| Popis: | As vaccines for COVID-19 were first being approved for use, there were widespread calls for it to be assigned a 'global public good'. However, allocating the COVID-19 vaccine globally poses a novel challenge of redistribution, one that cannot be effectively undertaken using current mechanisms for the dispensation of aid. An examination of the origins and implicit logic of global public goods theory shows that it would not be effective as a framework in this context. I argue that while it is a useful rhetorical tool to underscore the need for global access, it fails to account for concerns arising out of structural inequities between countries in the Global South and North. In addition to being ill-defined, the phrase encodes a neoliberal logic - one that prioritises the protection of private capital over democratic claims of redistribution and social justice. To ensure global access, our attention must be focussed instead on explicitly accounting for inequities, securing access for countries in the Global South and addressing the norm-setting powers of pharmaceutical companies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|